Seeburger Joerg, Kuntze Thomas, Mohr Friedrich W
Department of Cardiac Surgery, Heartcenter Leipzig University, Leipzig, Germany.
Semin Thorac Cardiovasc Surg. 2007 Summer;19(2):111-5. doi: 10.1053/j.semtcvs.2007.05.003.
Mitral valve repair with Gore-Tex (W.L. Gore & Assoc, Inc, Flagstaff, AZ) neochordae is of increasing interest. In 2000, the loop technique using premeasured Gore-Tex neochordae was introduced by our group. Herein, we report our experience with this technique in minimally invasive mitral valve repair (MVR) for degenerative disease. Between 1999 and 2006, 468 patients (328 men and 140 women) underwent elective MVR using neochordae at our institution. The mean age of the patients was 58 +/- 12.3 years. All patients had significant mitral valve regurgitation, and the mean severity was 3.5 +/- 0.6. Prolapse of the posterior leaflet was diagnosed in 393 patients (84%), and prolapse of the anterior leaflet was diagnosed in 250 patients (53.4%). Mean left ventricular function was 64.8 +/- 12.3%. All patients were operated on with the minimally invasive approach via a right lateral mini-thoracotomy, femoral cannulation for cardiopulmonary bypass, and the transthoracic direct clamp technique. Mean duration of cardiopulmonary bypass was 136 +/- 40 minutes, and mean aortic clamp time was 87 +/- 31 minutes. Gore-Tex neochordae were used in 149 patients (32%) on both leaflets, in 224 patients (47.7%) on the posterior leaflet only, and in 95 patients (20.3%) on the anterior leaflet only. A mean number of 2.7 +/- 1 loops at a mean length of 21 +/- 3.3 mm were used on the A2 segment. On the P2 segment, a mean number of 3.2 +/- 1 loops at a mean length of 14.3 +/- 3.1 mm were applied. The intraoperative course was uneventful in all patients. Early reoperation for bleeding had to be performed in 18 patients (3.9%). Mean duration of hospital stay was 11.9 +/- 13 days. The 30-day mortality rate was 1.5% (7 patients), and 1-year mortality rate was 2.6% (12 patients). MVR with neochordae and the loop technique is an easy and effective treatment for degenerative mitral valve disease. The procedure is reliable and reproducible, leading to low morbidity and mortality. Thus, use of Gore-Tex neochordae has become the standard technique for MVR at our institution.
采用戈尔特斯(W.L. Gore & Assoc, Inc, 弗拉格斯塔夫, 亚利桑那州)人造腱索进行二尖瓣修复越来越受到关注。2000年,我们团队引入了使用预先测量好的戈尔特斯人造腱索的套圈技术。在此,我们报告该技术在退行性疾病的微创二尖瓣修复(MVR)中的应用经验。1999年至2006年期间,我们机构有468例患者(328例男性和140例女性)接受了使用人造腱索的择期MVR。患者的平均年龄为58±12.3岁。所有患者均有明显的二尖瓣反流,平均严重程度为3.5±0.6。393例患者(84%)诊断为后叶脱垂,250例患者(53.4%)诊断为前叶脱垂。平均左心室功能为64.8±12.3%。所有患者均通过右外侧小切口、股动静脉插管进行体外循环以及经胸直接钳夹技术的微创方法进行手术。平均体外循环时间为136±40分钟,平均主动脉阻断时间为87±31分钟。149例患者(32%)在两个瓣叶上使用了戈尔特斯人造腱索,224例患者(47.7%)仅在后叶上使用,95例患者(20.3%)仅在前叶上使用。在A2节段平均使用2.7±1个套圈,平均长度为21±3.3毫米。在P2节段,平均使用3.2±1个套圈,平均长度为14.3±3.1毫米。所有患者术中过程均顺利。18例患者(3.9%)因出血需要早期再次手术。平均住院时间为11.9±13天。30天死亡率为1.5%(7例患者),1年死亡率为2.6%(12例患者)。使用人造腱索和套圈技术的MVR是治疗退行性二尖瓣疾病的一种简单有效的方法。该手术可靠且可重复,导致低发病率和死亡率。因此,使用戈尔特斯人造腱索已成为我们机构MVR的标准技术。